Blood biomarkers of hepatocellular carcinoma: a critical review
Junsheng Zhao, Zekai Hu, Xiaoping Zheng, Yajie Lin, Xiao Liu, Junjie Zhang, Jing Peng, Hainv Gao · 2024
Read Blood biomarkers of hepatocellular carcinoma: a critical review by Junsheng Zhao, Zekai Hu, Xiaoping Zheng, Yajie Lin, Xiao Liu, Junjie Zhang, Jing Peng, Hainv Gao (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621223.txt.
Description
Liver cancer is often found late, and the standard blood marker misses many early cases. Zhao and co-authors review the search for better blood tests, spanning protein markers, DNA mutations, chemical marks on DNA, and several kinds of RNA. Much of the review focuses on cell-free DNA analysis, the technology for reading tumor traces in a blood draw.
They weigh why so many promising markers stall before clinic use: methods differ between labs, tumors vary between patients, and signals are faint early on. The authors map the technical and biological hurdles that, if cleared, would sharpen early detection and follow-up care for this deadly cancer.
Catalog record
| CREATOR | Junsheng Zhao, Zekai Hu, Xiaoping Zheng, Yajie Lin, Xiao Liu, Junjie Zhang, Jing Peng, Hainv Gao |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |